| Literature DB >> 29028843 |
Cindy Wenke1, Janina Pospiech1, Tobias Reutter2, Uwe Truyen1, Stephanie Speck1.
Abstract
Air filtration has been shown to be efficient in reducing pathogen burden in circulating air. We determined at laboratory scale the retention efficiency of different air filter types either composed of a prefilter (EU class G4) and a secondary fiberglass filter (EU class F9) or consisting of a filter mat (EU class M6 and F8-9). Four filter prototypes were tested for their capability to remove aerosol containing equine arteritis virus (EAV), porcine reproductive and respiratory syndrome virus (PRRSV), bovine enterovirus 1 (BEV), Actinobacillus pleuropneumoniae (APP), and Staphylococcus (S.) aureus from air. Depending on the filter prototype and utilisation, the airflow was set at 1,800 m3/h (combination of upstream prefilter and fiberglass filter) or 80 m3/h (filter mat). The pathogens were aerosolized and their concentration was determined in front of and behind the filter by culture or quantitative real-time RT-PCR. Furthermore, survival of the pathogens over time in the filter material was determined. Bacteria were most efficiently filtered with a reduction rate of up to 99.9% depending on the filter used. An approximately 98% reduction was achieved for the viruses tested. Viability or infectivity of APP or PRRSV in the filter material decreased below the detection limit after 4 h and 24 h, respectively, whereas S. aureus was still culturable after 4 weeks. Our results demonstrate that pathogens can efficiently be reduced by air filtration. Consequently, air filtration combined with other strict biosecurity measures markedly reduces the risk of introducing airborne transmitted pathogens to animal facilities. In addition, air filtration might be useful in reducing bioaerosols within a pig barn, hence improving respiratory health of pigs.Entities:
Mesh:
Year: 2017 PMID: 29028843 PMCID: PMC5640248 DOI: 10.1371/journal.pone.0186558
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Technical information of the filter prototypes.
| Characteristic | Filter 1 | Filter 2 | Filter 3 | Filter 4 | ||
|---|---|---|---|---|---|---|
| Prefilter | Secondary filter | Prefilter | Secondary filter | |||
| Panel filter | Compact filter | Panel filter | Compact filter | Filter mat | Filter wool with glass fiber | |
| Polyester | Glass fiber | Synthetic-organic fiber | Glass fiber | Polyester | Glass wool | |
| Thickness 3 mm | Thickness | Thickness 0.2 mm | Thickness 0.6 mm | Thickness 25 mm | Thickness 2 x 40 mm | |
| Base Weight | Base Weight | Base Weight | Base Weight | Base Weight | Base Weight | |
| 592 x 592 x 48 | 592 x 592 x 292 | 595 x 595 x 48 | 593 x 593 x 292 | 1,200 x 1,200 | 1,200 x 1,200 | |
| 1.2 m2 | 18.8 m2 | 1.1 m2 | 18 m2 | 1.35 m2 | 1.35 m2 | |
| 70 Pa at 2.7 m/s | 110 Pa at 2.7 m/s | 75 Pa at 2.7 m/s | 105 Pa at 2.7 m/s | 20 Pa at 0.1 m/s | 50 Pa at 0.1 m/s | |
| G4 | F9 | G4 | F9 | M6 | approx. F8–F9 | |
| MERV 6–8 | MERV 16 | MERV 6–8 | MERV 16 | MERV 9–13 | MERV 14–16 | |
MERV-minimum efficiency reported value
* not tested according to EN 779 [9]
Fig 1Schematic design of the test chamber.
A: first sampling point in front of the filter, B: second sampling point behind the filter. Dimensions are given in mm.
Retention efficiency determined for the different filter prototypes.
| Pathogen | Prototype | Pathogen amount | Reduction efficiency (%) ± standard deviation | ||
|---|---|---|---|---|---|
| in culture suspension filled into the atomizer | in front of the filter | behind the filter | |||
| EAV | 1 | 107.5 TCID50/ml | 103.7 TCID50/ml | 102.1 TCID50/ml | 97.5 ± 1.19 |
| 2 | 106.7 TCID50/ml | 103.6 TCID50/ml | 102.0 TCID50/ml | 97.5 ± 2.36 | |
| 3 | 107.6 TCID50/ml | 105.0 TCID50/ml | 103.6 TCID50/ml | 96.0 ± 13.01 | |
| 4 | 107.3 TCID50/ml | 104.7 TCID50/ml | 102.8 TCID50/ml | 98.7 ± 1.26 | |
| 1 | 6.2 x 108 cfu/ml | 5.4 x 105 cfu/ml | 7.2 x 103 cfu/ml | 98.6 ± 0.29 | |
| 2 | 1.5 x 108 cfu/ml | 3.2 x 105 cfu/ml | 2.6 x 103 cfu/ml | 99.2 ± 0.21 | |
| 4 | 1.3 x 108 cfu/ml | 5.4 x 105 cfu/ml | 9.1 x 101 cfu/ml | 99.97 ± 0.07 | |
| PRRSV | 1 | 105.8 TCID50/ml | 103.8 TCID50/ml | 102.1 TCID50/ml | 98.0 ± 1.05 |
| 4 | 105.3 TCID50/ml | 102.9 TCID50/ml | 101.8 TCID50/ml | 92.1 ± 5.96 | |
| BEV | 1 | 1.5 x 1010 copies/μl template | 5.6 x 106 copies/μl template | 1.9 x 105 copies/μl template | 96.0 ± 2.90 |
| 4 | 1.5 x 1010 copies/μl template | 1.2 x 108 copies/μl template | 1.5 x 106 copies/μl template | 98.7 ± 0.72 | |
| 1 | 3.8 x 108 cfu/ml | 2.8 x 103 cfu/ml | 1.6 x 102 cfu/ml | 95.2 ± 3.34 | |
| 4 | 3.5 x 108 cfu/ml | 6.7 x 104 cfu/ml | 6.5 x 101 cfu/ml | 99.9 ± 0.05 | |
| 1 | 3.6 x 106 cfu/ml | 0 cfu/ml | 0 cfu/ml | na | |
| 1.3 x 107 cfu/ml | 0 cfu/ml | 0 cfu/ml | na | ||
TCID—tissue culture infectious dose; cfu–colony-forming units; na–not applicable
*sorted out after the first experiments due to compaction of the filter matter
#excluded because of economic reasons
$determined by quantitative real-time RT-PCR
Kinetics of infectivity in the filter material.
| Pathogen | Prototype | Pathogen infectivity after selected points in time | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.5 h | 1 h | 2 h | 4 h | 24 h | 48 h | 1 w | 4 w | 6 m | |||
| 1 | PF | nd | nd | nd | nd | + | + | + | + | - | |
| SF | nd | nd | nd | nd | + | - | + | + | - | ||
| 2 | PF | nd | nd | nd | nd | + | + | + | - | nd | |
| SF | nd | nd | nd | nd | + | + | + | - | nd | ||
| 4 | glass wool | nd | nd | nd | nd | + | + | + | - | nd | |
| PRRSV | 1 | PF | - | - | - | - | - | - | - | - | nd |
| SF | + | + | + | + | + | - | - | - | nd | ||
| 4 | glass wool | + | - | + | + | + | - | - | nd | nd | |
| BEV | 1 | PF | - | - | - | - | - | - | nd | nd | nd |
| SF | - | - | - | - | - | - | nd | nd | nd | ||
| 4 | glass wool | - | - | - | - | - | - | nd | nd | nd | |
| 1 | PF | + | + | + | + | - | - | - | nd | nd | |
| SF | + | + | + | + | - | - | - | nd | nd | ||
| 4 | glass wool | + | + | - | + | - | - | - | nd | nd | |
PF–Prefilter; SF—Secondary filter; nd-not done; h- hour; w-week; m-month; + bacterial /viral growth; − no bacterial /viral growth